High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer

• Lisa Svartdal Normann,

  Roles Formal analysis, Methodology, Writing – original draft

  Affiliations Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway, Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway, Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway

  https://orcid.org/0000-0003-3218-0344

  ⨯
• Mads Haugland Haugen,

  Roles Formal analysis, Writing – review & editing

  Affiliation Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

  ⨯
• Vesa Hongisto,

  Roles Formal analysis, Writing – review & editing

  Affiliation Division of Toxicology, Misvik Biology, Turku, Finland

  ⨯
• Miriam Ragle Aure,

  Roles Formal analysis, Writing – review & editing

  Affiliation Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway

  ⨯
• Suvi-Katri Leivonen,

  Roles Methodology, Writing – review & editing

  Affiliation Applied Tumor Genomics Research Program, Medical Faculty, University of Helsinki, Helsinki, Finland

  https://orcid.org/0000-0003-3224-0757

  ⨯
• Vessela N. Kristensen,

  Roles Supervision, Writing – review & editing

  Affiliation Department of Medical Genetics, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo and Oslo University Hospital, Oslo, Norway

  ⨯
• Andliena Tahiri,

  Roles Formal analysis, Resources, Writing – review & editing

  Affiliation Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway

  https://orcid.org/0000-0002-9221-1424

  ⨯
• Olav Engebraaten,

  Roles Formal analysis, Writing – review & editing

  Affiliations Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway, Department of Oncology, Oslo University Hospital, Oslo, Norway, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway

  ⨯
• Kristine Kleivi Sahlberg ,

  Contributed equally to this work with: Kristine Kleivi Sahlberg, Gunhild Mari Mælandsmo

  Roles Conceptualization, Supervision, Visualization, Writing – review & editing

  * E-mail: Kristine.Sahlberg@vestreviken.no

  Affiliations Department of Research and Innovation, Vestre Viken Hospital Trust, Drammen, Norway, Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway

  https://orcid.org/0000-0002-7281-2759

  ⨯
• Gunhild Mari Mælandsmo

  Contributed equally to this work with: Kristine Kleivi Sahlberg, Gunhild Mari Mælandsmo

  Roles Conceptualization, Supervision, Visualization, Writing – review & editing

  Affiliations Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway, Institute for Medical Biology, Faculty of Health Sciences, UiT–The Arctic University of Norway, Tromsø, Norway

  ⨯